Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,329,403 papers from all fields of science
Search
Sign In
Create Free Account
eplerenone
Known as:
eplerenon
, 9,11alpha-Epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, Methyl Ester
, eplerenone [Chemical/Ingredient]
Expand
A selective aldosterone receptor antagonist. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, thereby…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Arterial Vasodilation [PE]
Decreased Blood Pressure [PE]
Diabetes Mellitus, Non-Insulin-Dependent
Hypertensive disease
Expand
Narrower (1)
Inspra
Broader (2)
Mineralocorticoid Receptor Antagonists
Spironolactone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
New Stability Indicating Liquid Chromatographic Method for the Determination of Eplerenone in the Presence of Internal Standard
M. M. Annapurna
2018
Corpus ID: 56190062
Introduction: A simple stability indicating reverse-phase high-performance liquid chromatographic (RP-HPLC) method has been…
Expand
2016
2016
ENVIRONMENTALLY FRIENDLY LC/MS DETERMINATION OF EPLERENONE IN HUMAN PLASMA.
Katarzyna Buś-Kwaśnik
,
Monika Filist
,
P. Rudzki
Acta Poloniae Pharmaceutica - Drug Research
2016
Corpus ID: 4746958
Eplerenone (EPL), a selective aldosterone receptor antagonist, is indicated in the treatment of chronic heart failure and…
Expand
2013
2013
PREPARATION AND IN VITRO EVALUATION OF CHITOSAN MICROSPHERES OF EPLERENONE
P. Sriram
,
Deepak Kamlekar
,
Sujitha Hazari
2013
Corpus ID: 45409460
Objective: To develop and evaluate Eplerenone (EP) microspheres using natural polymer like Chitosan. Eplerenone is a suitable…
Expand
2012
2012
Development and Validation of Gradient RP-HPLC for Estimation of Impurities in Eplerenone Tablet dosage form
M. Naresh
,
C. Reddy
2012
Corpus ID: 96493756
A simple reverse phase gradient HPLC method used for simultaneous identification of Eplerenone impurities in market tablet dosage…
Expand
2011
2011
Aldosterone antagonists--last man standing?
P. Armstrong
New England Journal of Medicine
2011
Corpus ID: 205076686
The transformation of cardiac care over the past half century has been breathtaking to witness. In large part, this…
Expand
2011
2011
Eplerenone in mild heart failure.
D. Pascual-Figal
,
J. Sánchez-Más
,
J. Januzzi
New England Journal of Medicine
2011
Corpus ID: 32934943
1. Department of Health and Human Services. OPTN/SRTR annual report 2009. (http://optn.transplant.hrsa.gov/ar2009.) 2. Haynes L…
Expand
2011
2011
Co-prescription of co-trimoxazole and spironolactone in elderly patients
Li Wei
,
T. MacDonald
,
I. Mackenzie
British medical journal
2011
Corpus ID: 36731234
The combination should be used with caution because of the risk of hyperkalaemia
2010
2010
Heart failure: Placing an EMPHASIS on the mineralocorticoid receptor—benefit of eplerenone in mild HF
Alexandra King
Nature Reviews Cardiology
2010
Corpus ID: 38880527
Heart failure: Placing an EMPHASIS on the mineralocorticoid receptor—benefit of eplerenone in mild HF
Review
2005
Review
2005
Aldosterone receptor antagonists in the medical management of chronic heart failure.
W. Tang
,
Anoop C. Parameswaran
,
A. Maroo
,
Gary S. Francis
Mayo Clinic proceedings
2005
Corpus ID: 25201957
The benefits of aldosterone receptor antagonists (spironolactone and eplerenone) for patients with heart failure were shown in 2…
Expand
2000
2000
Absorption and Disposition of a Selective Aldosterone Receptor Antagonist, Eplerenone, in the Dog
C. Cook
,
Liming Zhang
,
J. Fischer
Pharmaceutical Research
2000
Corpus ID: 23057720
AbstractPurpose. The present study was conducted to characterize the pharmacokinetics of eplerenone (EP), a selective aldosterone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required